About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by PepGen Inc.

News headline image
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen to Participate in Upcoming Investor Conferences
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Pricing of $100 Million Public Offering
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Proposed Public Offering
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen to Focus on Development of Promising DM1 Program Following 10 mg/kg PGN-EDO51 Update
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Appoints Kasra Kasraian, PhD, as Chief Technology Officer
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Appointment of Two New Directors to its Board
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen to Participate in Upcoming Investor Conferences
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces CONNECT Program Updates
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 Phase 2 Study of PGN-EDO51 for Duchenne Muscular Dystrophy
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen to Participate in Upcoming Investor Conferences
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Presentations at the 29th Annual Congress of the World Muscle Society
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Christopher Ashton, PhD, to Retire from its Board of Directors
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Vice President, Research & Development
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Appoints Paul Streck, M.D., MBA, as Executive Vice President, Head of Research & Development
From PepGen Inc.
Via Business Wire
Tickers PEPG
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.